| 2.9 |
11.6 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 2.1 |
6.3 |
GO:0050894 |
determination of affect(GO:0050894) |
| 1.9 |
5.7 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 1.5 |
4.5 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 1.5 |
8.9 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.8 |
2.5 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.7 |
2.2 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.7 |
2.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.7 |
2.9 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.7 |
1.4 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.7 |
2.1 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.7 |
2.8 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.6 |
1.9 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.6 |
2.5 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.6 |
1.2 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.6 |
3.6 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.6 |
1.8 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.6 |
1.7 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.6 |
1.7 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.6 |
1.7 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.6 |
1.7 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.6 |
10.5 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.5 |
2.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.5 |
1.6 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.5 |
0.5 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.5 |
1.5 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.5 |
2.0 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.5 |
1.5 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.5 |
4.0 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.5 |
1.5 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.5 |
5.9 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.5 |
3.3 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.5 |
1.4 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.5 |
0.5 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.5 |
0.5 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.5 |
1.4 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.5 |
1.4 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.5 |
1.4 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.5 |
3.7 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.4 |
1.3 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.4 |
2.7 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.4 |
2.2 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.4 |
3.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 |
2.1 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.4 |
1.3 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 |
2.1 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.4 |
2.5 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.4 |
1.2 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.4 |
2.0 |
GO:2000691 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.4 |
1.2 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.4 |
2.4 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.2 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.4 |
0.8 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.4 |
1.6 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.4 |
0.8 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.4 |
1.9 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.4 |
0.8 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.4 |
0.4 |
GO:0060516 |
primary prostatic bud elongation(GO:0060516) |
| 0.4 |
1.1 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.4 |
1.1 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.4 |
0.4 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.4 |
1.1 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.4 |
2.5 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 |
1.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.4 |
1.4 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.4 |
2.8 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.4 |
1.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 |
1.7 |
GO:0050932 |
positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) |
| 0.3 |
8.7 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 |
1.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
12.0 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.3 |
1.0 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.3 |
4.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.3 |
1.7 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.3 |
1.3 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.3 |
1.0 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.3 |
0.7 |
GO:0010544 |
negative regulation of platelet activation(GO:0010544) |
| 0.3 |
1.3 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.3 |
2.0 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.3 |
7.6 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.3 |
1.6 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 |
0.6 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.3 |
0.9 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 |
4.4 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.3 |
0.9 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.3 |
0.9 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.3 |
1.2 |
GO:0061349 |
cardiac right atrium morphogenesis(GO:0003213) chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.3 |
0.6 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 |
3.1 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.3 |
1.8 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 |
5.8 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
1.8 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.3 |
0.9 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.3 |
0.9 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.3 |
0.3 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.3 |
0.3 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.3 |
2.7 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 |
1.2 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) dTMP metabolic process(GO:0046073) |
| 0.3 |
1.2 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 |
0.9 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 |
4.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.3 |
2.0 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 |
0.6 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.3 |
0.6 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.3 |
3.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 |
0.8 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 |
0.8 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.3 |
1.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.3 |
1.1 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.3 |
1.9 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.3 |
0.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.3 |
2.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
0.8 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 |
1.6 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
0.3 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.3 |
2.4 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.3 |
0.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.3 |
0.3 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.3 |
2.6 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.3 |
1.6 |
GO:0061053 |
somite development(GO:0061053) |
| 0.3 |
1.0 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.3 |
1.0 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.3 |
0.8 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.3 |
0.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.3 |
1.5 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.3 |
0.8 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.3 |
2.1 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.3 |
0.3 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.3 |
0.8 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.3 |
1.0 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.3 |
1.0 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 |
0.3 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.3 |
1.8 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.3 |
1.0 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 |
1.5 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 |
1.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.3 |
1.0 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.3 |
2.5 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.3 |
0.3 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.2 |
1.7 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.7 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.2 |
1.0 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.2 |
1.5 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
1.2 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
1.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
3.2 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.2 |
1.9 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
2.4 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.2 |
0.5 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.2 |
0.9 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.2 |
1.4 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.2 |
0.7 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.2 |
7.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 |
0.9 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 |
2.6 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
1.6 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.2 |
0.5 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.2 |
0.7 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.2 |
0.7 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 |
1.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
1.4 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 |
1.4 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
0.9 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 |
1.8 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.2 |
1.6 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
0.4 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 |
0.2 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 |
3.3 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
1.3 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.2 |
2.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
0.7 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.2 |
3.1 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.2 |
0.4 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 |
1.1 |
GO:0009183 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.2 |
0.2 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.2 |
1.5 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
0.9 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
1.3 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
2.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.2 |
0.6 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 |
0.9 |
GO:0014806 |
smooth muscle hyperplasia(GO:0014806) |
| 0.2 |
1.5 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 |
1.7 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.2 |
0.2 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
2.7 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
1.9 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.2 |
0.8 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.2 |
0.6 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.2 |
0.4 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
0.2 |
GO:2001182 |
regulation of interleukin-12 secretion(GO:2001182) |
| 0.2 |
2.3 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
0.2 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.2 |
0.2 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 |
0.6 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 |
1.4 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.2 |
0.4 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 |
0.8 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.2 |
1.6 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
0.8 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.2 |
1.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.2 |
2.2 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 0.2 |
1.0 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.2 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 |
0.4 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.2 |
1.0 |
GO:0070142 |
synaptic vesicle budding(GO:0070142) |
| 0.2 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.2 |
1.2 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 |
0.8 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 |
3.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
1.0 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 |
0.6 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 |
0.8 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
1.0 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
0.2 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.2 |
2.0 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
1.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.2 |
0.8 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.2 |
0.4 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.2 |
2.1 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.2 |
1.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
1.2 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 |
2.5 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
4.2 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
0.6 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.2 |
0.8 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.2 |
1.1 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.2 |
0.6 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 |
0.9 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
0.6 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.2 |
4.6 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
1.8 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 |
0.6 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 |
0.9 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 |
0.2 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.2 |
0.2 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.2 |
2.0 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.2 |
3.8 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 |
1.6 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
0.5 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.2 |
0.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.2 |
0.5 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 |
1.4 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
0.9 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 |
0.5 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 |
1.1 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.2 |
1.3 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.2 |
2.9 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.2 |
1.2 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
0.2 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.2 |
0.5 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.2 |
1.0 |
GO:0042560 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
1.0 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.2 |
0.7 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
3.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.2 |
0.9 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 |
0.7 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 |
0.2 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.2 |
0.7 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.5 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 |
2.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
1.2 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.2 |
0.7 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
1.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.2 |
1.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
0.5 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.2 |
0.7 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.2 |
1.7 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 |
0.5 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.2 |
1.0 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.2 |
0.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
1.9 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.3 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.2 |
1.0 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.2 |
1.3 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
0.5 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.5 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 |
3.6 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
0.3 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 |
1.3 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 |
1.6 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.2 |
0.8 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.2 |
0.2 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 |
0.7 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 |
0.3 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.2 |
0.7 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.2 |
0.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
0.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.6 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.2 |
0.2 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.2 |
0.8 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.2 |
0.6 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 |
0.2 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.2 |
1.4 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 |
0.6 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.2 |
2.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
2.7 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.5 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 |
0.6 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.2 |
0.5 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 |
0.2 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.2 |
0.6 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.2 |
0.9 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.2 |
0.3 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.2 |
0.3 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.2 |
0.3 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.2 |
0.3 |
GO:1901983 |
regulation of protein acetylation(GO:1901983) |
| 0.2 |
0.6 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.2 |
0.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
1.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
1.2 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.1 |
0.4 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.6 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.6 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.1 |
0.4 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.1 |
0.7 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
0.4 |
GO:0072684 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.1 |
0.4 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 |
2.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.9 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.4 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.4 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 |
0.4 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.3 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 |
0.4 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 |
1.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
1.2 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.1 |
GO:0006206 |
pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.1 |
1.0 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
1.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.1 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 |
0.3 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 |
0.1 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
0.6 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.1 |
0.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
1.0 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.6 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.1 |
1.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.6 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.7 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.7 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.1 |
0.3 |
GO:0097107 |
postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
| 0.1 |
1.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
6.0 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.1 |
0.6 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.4 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
0.8 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 |
1.5 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.7 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 |
0.1 |
GO:0042398 |
cellular modified amino acid biosynthetic process(GO:0042398) |
| 0.1 |
0.4 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
2.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
1.0 |
GO:2000782 |
regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.1 |
0.1 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.1 |
0.4 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
0.5 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
0.4 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
1.2 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
0.7 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
0.5 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.1 |
0.4 |
GO:0090114 |
COPII-coated vesicle budding(GO:0090114) |
| 0.1 |
0.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
1.6 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.4 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.1 |
1.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
1.1 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.3 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.4 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.3 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.3 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
1.1 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.5 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.1 |
1.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
1.7 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
1.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.1 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
2.1 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
0.3 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
0.9 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
2.0 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.4 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.1 |
GO:0060687 |
regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.1 |
0.3 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.1 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.1 |
2.5 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.4 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.5 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.1 |
0.4 |
GO:0086010 |
membrane depolarization(GO:0051899) membrane depolarization during action potential(GO:0086010) |
| 0.1 |
0.7 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.1 |
0.5 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.1 |
0.4 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.1 |
0.8 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
1.4 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.4 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.3 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.1 |
0.4 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.5 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
1.9 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 |
0.6 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 |
0.5 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
1.0 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.4 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.4 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.1 |
0.5 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
2.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.4 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 |
2.9 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
1.5 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.8 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.8 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
0.6 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
0.1 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.1 |
1.0 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 |
0.4 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.1 |
1.9 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.4 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 |
0.4 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 |
0.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
0.9 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
1.5 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.6 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
0.6 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 |
0.2 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
0.4 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
1.0 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.1 |
0.1 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.1 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.5 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.1 |
0.4 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 |
0.1 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.1 |
0.4 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.1 |
0.4 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
4.8 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.1 |
3.1 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
0.4 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.1 |
1.1 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.1 |
0.4 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) regulation of melanosome transport(GO:1902908) positive regulation of melanosome transport(GO:1902910) |
| 0.1 |
0.2 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.1 |
0.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.1 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.1 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.1 |
4.5 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.7 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
0.1 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.5 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
1.0 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.8 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.5 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
1.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
0.6 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 |
2.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.3 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.1 |
2.8 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.5 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.3 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.1 |
0.3 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
0.7 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.1 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.3 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
0.3 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.1 |
0.3 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
2.0 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.1 |
GO:2000452 |
CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.1 |
0.9 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
2.9 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 |
0.1 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.1 |
0.9 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.1 |
GO:0090269 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.1 |
0.3 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 |
0.1 |
GO:0045073 |
regulation of chemokine biosynthetic process(GO:0045073) |
| 0.1 |
0.3 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.8 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.1 |
0.4 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
0.2 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
1.3 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.3 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.6 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.2 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.1 |
0.6 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.1 |
0.3 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 |
1.0 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.2 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.1 |
1.0 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
2.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.5 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.5 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.2 |
GO:1903726 |
negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.1 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
1.1 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.4 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.1 |
0.2 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.8 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.8 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.1 |
0.3 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.1 |
0.4 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.3 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 |
0.2 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.1 |
0.8 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.5 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.7 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.7 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.1 |
0.3 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.1 |
0.6 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.2 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.1 |
0.2 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.1 |
2.4 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.6 |
GO:0032960 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 0.1 |
0.6 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.4 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.1 |
0.3 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.1 |
0.4 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.1 |
0.3 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
1.0 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.7 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.6 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
0.6 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.6 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.6 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
1.4 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
2.1 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.1 |
1.2 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.1 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
1.3 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.9 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.4 |
GO:1901558 |
regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.1 |
1.5 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 |
0.2 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 |
1.7 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.3 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.1 |
0.4 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.1 |
1.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.8 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
1.0 |
GO:0060348 |
bone development(GO:0060348) |
| 0.1 |
0.5 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 |
0.5 |
GO:0060350 |
endochondral bone morphogenesis(GO:0060350) |
| 0.1 |
0.4 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.1 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.1 |
0.9 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.9 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
0.7 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
1.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.5 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
0.8 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.3 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.3 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.1 |
1.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.5 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.3 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.1 |
0.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
1.7 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.5 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
0.8 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.6 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.1 |
0.5 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.7 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.3 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.1 |
0.3 |
GO:0042747 |
circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.1 |
0.3 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.2 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.1 |
0.4 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.1 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 |
0.3 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
0.5 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.2 |
GO:0072237 |
metanephric proximal tubule development(GO:0072237) |
| 0.1 |
1.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.6 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
2.6 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.1 |
0.2 |
GO:0002065 |
columnar/cuboidal epithelial cell differentiation(GO:0002065) |
| 0.1 |
0.1 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 |
0.3 |
GO:0090501 |
RNA phosphodiester bond hydrolysis(GO:0090501) |
| 0.1 |
0.1 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.1 |
0.1 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
0.8 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.5 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.1 |
0.3 |
GO:0051311 |
meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.1 |
0.5 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.1 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.1 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.1 |
0.1 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.1 |
0.4 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.1 |
0.3 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 |
0.4 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.1 |
GO:1904882 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.1 |
0.4 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.9 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.8 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.3 |
GO:1902750 |
negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 |
2.4 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.2 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.1 |
0.2 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.1 |
0.2 |
GO:0019860 |
uracil metabolic process(GO:0019860) |
| 0.1 |
0.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.4 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.1 |
0.4 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.3 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.1 |
0.2 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.1 |
0.3 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.4 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.1 |
0.3 |
GO:0072364 |
regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.1 |
0.7 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 |
1.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
1.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.6 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.3 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.2 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
0.5 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.7 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 |
0.1 |
GO:0070423 |
nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 |
0.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.1 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.1 |
3.7 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
1.3 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.2 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.3 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.1 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 |
0.5 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 |
0.4 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.5 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.1 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
| 0.1 |
0.6 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.4 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.2 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.3 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.7 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.1 |
0.3 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.1 |
0.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.2 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.1 |
0.3 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.1 |
0.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.1 |
0.6 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 |
0.2 |
GO:1901201 |
regulation of extracellular matrix assembly(GO:1901201) |
| 0.1 |
0.5 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.2 |
GO:1903204 |
neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
0.3 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.1 |
1.3 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.3 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.1 |
0.1 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.1 |
0.4 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
1.9 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.3 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.1 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.2 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.2 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 |
0.1 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.1 |
0.2 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.8 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.2 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
0.2 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.1 |
0.5 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
1.0 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
1.1 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.1 |
0.7 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.3 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.2 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 |
0.3 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.1 |
0.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.4 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
1.0 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
2.0 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.3 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.2 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
0.5 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.5 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 |
0.2 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.1 |
0.1 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.1 |
0.5 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.2 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 |
1.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.4 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.7 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.5 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.2 |
GO:0060532 |
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.1 |
0.2 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.1 |
0.2 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.5 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.1 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
1.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.2 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
3.6 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.1 |
0.1 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.1 |
GO:0010998 |
regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
| 0.1 |
0.4 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.1 |
0.1 |
GO:0035787 |
cell migration involved in kidney development(GO:0035787) |
| 0.1 |
0.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.7 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.1 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.1 |
0.4 |
GO:0072711 |
cellular response to hydroxyurea(GO:0072711) |
| 0.1 |
1.7 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.1 |
0.1 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
0.1 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.1 |
0.2 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
0.2 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 |
0.2 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 |
1.3 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 |
1.5 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.4 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
2.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.9 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
0.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.1 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.1 |
0.6 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.2 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 |
0.1 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 |
0.1 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.1 |
0.3 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.4 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
0.1 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.4 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
1.5 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
0.5 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.1 |
0.3 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.1 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
| 0.1 |
0.4 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 |
0.3 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.1 |
2.5 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
1.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
4.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.4 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
0.3 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 |
0.1 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.1 |
0.1 |
GO:1904938 |
dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.1 |
0.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.1 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.1 |
0.1 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
0.3 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.3 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
0.6 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
1.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.3 |
GO:0032804 |
regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.1 |
0.4 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.9 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.9 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.1 |
0.4 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
0.4 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 |
0.3 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.1 |
0.7 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
0.8 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
3.6 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
0.7 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
4.7 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.2 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.1 |
1.1 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.4 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.1 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.1 |
0.9 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.1 |
0.3 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
1.0 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.5 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
0.1 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
0.5 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.1 |
1.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
1.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.4 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
1.0 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
1.8 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.1 |
0.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
0.7 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
0.1 |
GO:0002476 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.1 |
0.4 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.3 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.1 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 |
0.1 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 |
0.3 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.2 |
GO:0021831 |
embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.1 |
4.3 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 |
0.1 |
GO:0060577 |
pulmonary vein morphogenesis(GO:0060577) |
| 0.1 |
0.4 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.3 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.2 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.1 |
0.4 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 |
0.9 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.1 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.4 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.1 |
0.4 |
GO:0090647 |
modulation of age-related behavioral decline(GO:0090647) |
| 0.1 |
0.2 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 |
1.0 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.1 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.1 |
0.1 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
| 0.1 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.5 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.2 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
0.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.1 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.1 |
0.4 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
0.1 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 |
3.5 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.1 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
0.5 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.2 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.1 |
0.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.2 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.1 |
0.3 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.9 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.1 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.1 |
0.2 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.6 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.6 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
1.1 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
1.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.2 |
GO:0042559 |
folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 |
0.2 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 |
0.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.1 |
0.3 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.4 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 |
0.6 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 |
0.1 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.1 |
0.2 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.1 |
GO:0010921 |
regulation of phosphatase activity(GO:0010921) |
| 0.1 |
0.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.2 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
3.6 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
0.3 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.3 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.4 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.2 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 |
0.3 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.1 |
0.2 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.2 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 |
0.8 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.1 |
0.4 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.2 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 |
1.8 |
GO:0061620 |
glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.1 |
0.3 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.3 |
GO:0007098 |
centrosome cycle(GO:0007098) |
| 0.1 |
0.3 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
1.4 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.4 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 |
4.0 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
0.3 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.2 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.4 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.1 |
0.1 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.1 |
0.6 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
0.1 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.1 |
0.2 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
1.6 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
0.1 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 |
0.1 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 |
0.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.1 |
0.8 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.1 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 |
0.3 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 |
0.2 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.1 |
1.0 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
3.1 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.2 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
0.5 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.2 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.3 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.2 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 |
0.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
1.7 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
0.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.3 |
GO:1901545 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.1 |
0.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.7 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 |
0.3 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
1.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.1 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.1 |
0.1 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
6.7 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
1.5 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.1 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.1 |
0.3 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.1 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.1 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.1 |
1.1 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
1.0 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.1 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.3 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.1 |
0.3 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.4 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.6 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.4 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 |
0.1 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.3 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.0 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.0 |
0.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.3 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.0 |
0.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.6 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.3 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.9 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.2 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.3 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
1.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.1 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.1 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.0 |
0.3 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
0.1 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.2 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.0 |
0.5 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.2 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.0 |
0.0 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.4 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.2 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.0 |
1.7 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
1.0 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.1 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.0 |
0.1 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.0 |
0.2 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.0 |
0.4 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.0 |
0.1 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.0 |
0.0 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.4 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.0 |
0.5 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.0 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.3 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.5 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.0 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.0 |
0.1 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 |
1.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.1 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
0.2 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.0 |
0.1 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
0.4 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.4 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.1 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.0 |
4.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.5 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.0 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.0 |
0.2 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.1 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.0 |
0.1 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.0 |
0.2 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.2 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.0 |
0.4 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.6 |
GO:2001234 |
negative regulation of apoptotic signaling pathway(GO:2001234) |
| 0.0 |
0.1 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.0 |
0.7 |
GO:1904874 |
positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.0 |
0.0 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.8 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.0 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
0.4 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.1 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 |
0.2 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.0 |
0.6 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.1 |
GO:0045661 |
regulation of myoblast differentiation(GO:0045661) |
| 0.0 |
0.0 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
1.4 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.3 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
0.8 |
GO:1901186 |
positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 |
1.0 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 |
0.1 |
GO:0014842 |
skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.0 |
0.5 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.6 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
1.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.0 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.0 |
0.3 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
0.6 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.2 |
GO:0045338 |
farnesyl diphosphate metabolic process(GO:0045338) |
| 0.0 |
0.0 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.0 |
0.2 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 |
0.9 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 |
0.1 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.1 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.1 |
GO:0060676 |
ureteric bud formation(GO:0060676) |
| 0.0 |
0.3 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.0 |
0.4 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
1.6 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 |
1.1 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.5 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.0 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
1.3 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.3 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.1 |
GO:0018969 |
thiocyanate metabolic process(GO:0018969) |
| 0.0 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
1.0 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
1.4 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.8 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.5 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.1 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.0 |
0.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.3 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 |
0.3 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
0.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.1 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.0 |
0.2 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.2 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.0 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.3 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.2 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.2 |
GO:0021513 |
spinal cord dorsal/ventral patterning(GO:0021513) smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
| 0.0 |
0.1 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.0 |
0.2 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.3 |
GO:0019985 |
DNA synthesis involved in DNA repair(GO:0000731) translesion synthesis(GO:0019985) |
| 0.0 |
0.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 |
0.1 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 |
0.3 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 |
0.4 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.0 |
0.4 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.2 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
2.2 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.6 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.0 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.0 |
0.5 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.1 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.1 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.1 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 |
0.0 |
GO:0045350 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
| 0.0 |
0.9 |
GO:0051439 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.0 |
0.0 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.0 |
0.0 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.0 |
0.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.0 |
0.1 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.0 |
0.2 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.0 |
0.7 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.0 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.1 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.0 |
1.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.4 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.0 |
0.4 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.0 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
0.0 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.0 |
0.3 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.5 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.0 |
0.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.0 |
0.3 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.1 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 |
0.2 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.6 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.5 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.0 |
0.8 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.2 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.0 |
0.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.1 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.0 |
0.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.3 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.2 |
GO:0033158 |
regulation of protein import into nucleus, translocation(GO:0033158) |
| 0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.4 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.1 |
GO:0070091 |
glucagon secretion(GO:0070091) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:0043383 |
negative T cell selection(GO:0043383) |
| 0.0 |
0.1 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 |
0.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.0 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.0 |
0.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.2 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.1 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.6 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.0 |
GO:0051584 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.0 |
0.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.3 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.6 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.1 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.0 |
1.2 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
1.1 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 |
0.2 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.0 |
0.1 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.3 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.2 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.0 |
0.5 |
GO:0051299 |
mitotic centrosome separation(GO:0007100) centrosome separation(GO:0051299) |
| 0.0 |
0.4 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.0 |
1.4 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.2 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.0 |
0.5 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
1.5 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.0 |
0.3 |
GO:0000724 |
double-strand break repair via homologous recombination(GO:0000724) |
| 0.0 |
0.1 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.0 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
2.2 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.2 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.0 |
3.6 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.1 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.1 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.0 |
0.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
1.4 |
GO:2000181 |
negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 |
0.1 |
GO:0006188 |
IMP biosynthetic process(GO:0006188) |
| 0.0 |
0.2 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.8 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.9 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.1 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 |
0.9 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.0 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.1 |
GO:0019856 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 |
1.0 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.0 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.3 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.1 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.0 |
0.1 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 |
0.1 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
| 0.0 |
1.9 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.1 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.0 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.1 |
GO:0009180 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 |
0.2 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.3 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.0 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.0 |
0.1 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.1 |
GO:0010710 |
regulation of collagen catabolic process(GO:0010710) |
| 0.0 |
0.2 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.1 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.0 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.3 |
GO:0060789 |
hair follicle placode formation(GO:0060789) |
| 0.0 |
0.3 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.0 |
0.1 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.1 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.0 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.0 |
0.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.2 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.1 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.0 |
0.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.1 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.2 |
GO:0034620 |
cellular response to unfolded protein(GO:0034620) |
| 0.0 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
0.2 |
GO:0050672 |
negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.0 |
0.1 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.2 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
1.1 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.6 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.3 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.2 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.5 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.1 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.0 |
0.1 |
GO:0002545 |
microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.1 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
2.2 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.9 |
GO:1903307 |
positive regulation of regulated secretory pathway(GO:1903307) |
| 0.0 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
1.1 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.3 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 |
0.1 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.0 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.3 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.0 |
0.0 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.0 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.2 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.2 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) indole-containing compound metabolic process(GO:0042430) |
| 0.0 |
0.1 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.0 |
GO:1903979 |
regulation of microglial cell activation(GO:1903978) negative regulation of microglial cell activation(GO:1903979) |
| 0.0 |
2.0 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.3 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.6 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.3 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.0 |
GO:0003164 |
His-Purkinje system development(GO:0003164) Purkinje myocyte development(GO:0003165) |
| 0.0 |
0.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.0 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.0 |
0.0 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.0 |
0.1 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:0009953 |
dorsal/ventral pattern formation(GO:0009953) |
| 0.0 |
0.4 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) |
| 0.0 |
0.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 |
0.5 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.1 |
GO:0031341 |
regulation of cell killing(GO:0031341) |
| 0.0 |
0.0 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 |
0.0 |
GO:0051954 |
positive regulation of amine transport(GO:0051954) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.2 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.1 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.1 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.2 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.2 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.8 |
GO:0098840 |
protein transport along microtubule(GO:0098840) |
| 0.0 |
0.1 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.0 |
0.1 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.0 |
0.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.0 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.1 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 |
0.2 |
GO:1901028 |
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
| 0.0 |
0.1 |
GO:0018194 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
0.3 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.0 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 |
0.4 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.2 |
GO:1900077 |
negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.5 |
GO:0010907 |
positive regulation of glucose metabolic process(GO:0010907) |
| 0.0 |
0.0 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
0.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.1 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.0 |
0.1 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 |
0.0 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.1 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
4.7 |
GO:0000398 |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 |
0.2 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.0 |
0.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.1 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.0 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.6 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.3 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.0 |
0.1 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.2 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 |
0.2 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.3 |
GO:0002717 |
positive regulation of natural killer cell mediated immunity(GO:0002717) |
| 0.0 |
0.5 |
GO:0046464 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.0 |
0.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.1 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.0 |
0.1 |
GO:1904588 |
thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.0 |
0.0 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.0 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.2 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.1 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.2 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:0046502 |
uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.0 |
0.1 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.0 |
0.1 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.0 |
0.5 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.0 |
0.1 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.0 |
0.0 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.0 |
0.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.3 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.1 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.1 |
GO:0043300 |
regulation of leukocyte degranulation(GO:0043300) |
| 0.0 |
0.1 |
GO:0021517 |
ventral spinal cord development(GO:0021517) |
| 0.0 |
0.2 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.0 |
0.2 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
1.5 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.6 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.0 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.1 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.0 |
0.0 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.0 |
0.1 |
GO:0090208 |
positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.0 |
0.0 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.1 |
GO:0006090 |
pyruvate metabolic process(GO:0006090) |
| 0.0 |
0.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.1 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.0 |
0.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.3 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.0 |
GO:0032196 |
transposition(GO:0032196) |
| 0.0 |
0.0 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
0.0 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 |
0.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.4 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 |
0.4 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.2 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
1.0 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 |
0.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.1 |
GO:0018200 |
peptidyl-glutamic acid modification(GO:0018200) |
| 0.0 |
0.1 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 |
0.1 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.1 |
GO:1903543 |
positive regulation of exosomal secretion(GO:1903543) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.2 |
GO:1901889 |
negative regulation of cell junction assembly(GO:1901889) |
| 0.0 |
0.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.9 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
| 0.0 |
0.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.0 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.0 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.0 |
0.2 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
1.2 |
GO:1990830 |
response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 |
0.2 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.0 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.0 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.0 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 |
0.0 |
GO:0072235 |
metanephric distal tubule development(GO:0072235) |
| 0.0 |
0.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.0 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.0 |
0.4 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.0 |
0.1 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.0 |
0.2 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.4 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.0 |
0.1 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 |
0.1 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.1 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 |
0.1 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.0 |
0.0 |
GO:0003188 |
heart valve formation(GO:0003188) |
| 0.0 |
0.0 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.1 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.0 |
0.1 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.1 |
GO:0014902 |
myotube differentiation(GO:0014902) |
| 0.0 |
0.3 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.1 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.0 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.0 |
0.1 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.0 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.0 |
0.0 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.0 |
0.4 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
1.0 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.2 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.0 |
0.0 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.0 |
GO:0045872 |
regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.1 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.0 |
0.0 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.0 |
0.1 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
1.0 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.1 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
| 0.0 |
0.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.1 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.0 |
0.1 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.1 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.0 |
0.0 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.0 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
